REVERSAL OF DIRECT FACTOR XA INHIBITORS WITH ANDEXANET ALFA PRIOR TO INVASIVE OR SURGICAL PROCEDURES

被引：0
|
作者：
Bradshaw, Paige [1 ]
Philpott, Carolyn [1 ]
Droege, Christopher [1 ]
Droege, Molly [2 ]
Ernst, Neil [1 ]
Foertsch, Madeline [1 ]
Harger, Nicole [2 ]
Srinivasan, Vasisht [3 ]
Winter, Jessica [1 ]
Keegan, Shaun [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, UC Hlth, Cincinnati, OH 45267 USA
[3] Univ Washington, Sch Med, Seattle, WA 98195 USA
来源：
CRITICAL CARE MEDICINE | 2022年 / 50卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
908
引用
收藏
页码：450 / 450
页数：1
相关论文
共 50 条
  • [31] Andexanet Alfa to Reverse the Effect of Factor Xa Inhibitors in Intracranial Hemorrhage
    Frol, Senta
    Oblak, Janja Pretnar
    Sabovic, Miso
    Kermer, Pawel
    CNS DRUGS, 2023, 37 (06) : 477 - 487
  • [32] Andexanet Alfa to Reverse the Effect of Factor Xa Inhibitors in Intracranial Hemorrhage
    Senta Frol
    Janja Pretnar Oblak
    Mišo Šabovič
    Pawel Kermer
    CNS Drugs, 2023, 37 : 477 - 487
  • [33] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Ammar, Abdalla A.
    Ammar, Mahmoud A.
    Owusu, Kent A.
    Brown, Stacy C.
    Kaddouh, Firas
    Elsamadicy, Aladine A.
    Acosta, Julian N.
    Falcone, Guido J.
    NEUROCRITICAL CARE, 2021, 35 (01) : 255 - 261
  • [34] Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies
    Escolar, G.
    Diaz-Ricart, M.
    Arellano-Rodrigo, E.
    DRUGS OF TODAY, 2017, 53 (05) : 271 - 282
  • [35] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Abdalla A. Ammar
    Mahmoud A. Ammar
    Kent A. Owusu
    Stacy C. Brown
    Firas Kaddouh
    Aladine A. Elsamadicy
    Julián N. Acosta
    Guido J. Falcone
    Neurocritical Care, 2021, 35 : 255 - 261
  • [36] Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects
    Tanaka, Kenichi A.
    Levy, Jerrold H.
    BRITISH JOURNAL OF ANAESTHESIA, 2024, 132 (02) : 215 - 217
  • [37] Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent
    Levy, Jerrold H.
    Connors, Jean M.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (01) : 265 - 266
  • [38] Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors
    Milling, Jr Tuman J.
    Middeldorp, Saskia
    Xu, Lizhen
    Koch, Bruce
    Demchuk, Andrew
    Eikelboom, John W.
    Verhamme, Peter
    Cohen, Alexander T.
    Beyer-Westendorf, Jan
    Gibson, C. Michael
    Lopez-Sendon, Jose
    Crowther, Mark
    Shoamanesh, Ashkan
    Coppens, Michiel
    Schmidt, Jeannot
    Albaladejo, Pierre
    Connolly, Stuart J.
    CIRCULATION, 2023, 147 (13) : 1026 - 1038
  • [39] Andexanet Alfa for Reversing Factor Xa Inhibition
    Sible, Alexandra M.
    Nawarskas, James J.
    CARDIOLOGY IN REVIEW, 2019, 27 (02) : 108 - 111
  • [40] Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
    Lier, H.
    Grottke, O.
    ANAESTHESIST, 2016, 65 (12): : 940 - 941
12345